News Directory
Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at media@mtpconnect.org.au.
News
08 July 2021
REDI Bridge and BridgeTech Industry Fellowships announced
Twenty pharmaceutical and MedTech researchers, entrepreneurs and innovators from around Australia have been awarded with industry-based fellowships to boost skills and advance their research or technology towards commercialisation.
07 July 2021
In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To In June
Check out what MTPConnect got up to this month!
01 July 2021
Applications open for Supply Chain Resilience Initiative (SCRI) grants
Applications are now open for the Supply Chain Resilience Initiative (SCRI), part of the Australian Government’s $1.5 billion Modern Manufacturing Strategy.
30 June 2021
Drug Repurposing: Building the Path to Australian Success
Today we launch our latest report, a discussion paper – ‘Drug Repurposing: Building the Path to Australian Success’ – that explores the drug repurposing landscape in Australia and just what it will take to deliver more repurposed drugs in ways that improve people’s health.
24 June 2021
Let’s do more for Australians with diabetes and cardiovascular disease
Our Targeted Translation Research Accelerator (TTRA) initiative is currently engaging with the sector to identify unmet needs relating to the prevention, diagnosis, treatment, or management of diabetes and / or cardiovascular disease. We are reaching out to researchers, healthcare and medical professionals, industry stakeholders and those with knowledge of the lived experience of diabetes and cardiovascular disease.
16 June 2021
Successful COSA Tele-Trial Model implemented to help remote cancer patients across Australia
Access to clinical trials for people diagnosed with cancer is a core component of providing optimal cancer care through specialist cancer centres, hospitals and other treatment facilities. Patients living outside of major metropolitan centres face many barriers in accessing clinical trials.
03 June 2021
In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in May
Check out what MTPConnect got up to this month!
31 May 2021
Join our June WA MTP Sector Spotlight Series Event
Our next Perth-based event, set for 30 June, will feature a double act with Dr Simon Graindorge, Entrepreneur-in-Residence, IP Group Australia (and OncoRes Medical's COO) and Epichem’s CEO and Managing Director Colin LeGalia
28 May 2021
Industry Genomics Network Alliance Launches Strategic Plan
Industry leaders are collaborating through the Industry Genomics Network Alliance (InGeNA) to quantify the benefits of genomics to Australia and point to a future where precision healthcare is accessible to all.
27 May 2021
REDI initiative awards contracts to Biointelect and Cicada Innovations for workforce skills gap training and education
MTPConnect today announced its selection of additional industry training providers to deliver new programs addressing key skills gaps in product development and commercialisation in the medical technology, biotechnology and pharmaceutical (MTP) sector workforce.
24 May 2021
Join Our WA MTP Sector Spotlight Series Event with Resonance Health
The MTPConnect WA Life Sciences Innovation Hub is hosting the next MTP Sector Spotlight Series event in Perth this week to shine a light on Resonance Health, a global healthcare company based in WA, specialising in the development and delivery of non-invasive medical imaging software and analysis services to address liver disease.
20 May 2021
New Report: Australia’s Clinical Trials Sector Shows Healthy Growth
MTPConnect today marks International Clinical Trials Day 2021 with the release of a new report that reveals the size and scope of Australia’s clinical trials sector and opportunities for future growth.
14 May 2021
REDI News: APR.Intern Helps Genepath with PhD Internship to Fast Track Research
An innovative start-up has collaborated with The University of New South Wales (UNSW) to fast-track commercialisation of new genetic testing technology.